Experience in Liquid Ventilation

  • R. B. Hirschl
Conference paper


Perfluorocarbons are structurally similar to hydrocarbons with the hydrogen replaced by fluorine. The carbon chains vary in length and an additional moiety often is attached to the molecule which, together, give unique properties to each perfluorocarbon. In general, perfluorocarbons have excellent oxygen and carbon dioxide carrying capacity (50 ml 02/dl and 160-210 ml CO2/dl, respectively)[1]. They are clear, odorless, inert fluids which are immiscible in aqueous and most other solutions. They are relatively dense (1.7-1.9 gm/ml), have a low surface tension (15-19 dynes/cm), and are relatively volatile with vapor pressures which range from 11 to 85 torr at 37°C. The vapor pressure of the individual perfluorocarbon governs the rapidity with which it evaporates from the lungs after intratracheal administration. As is demonstrated in Fig. 1, perflubron (LiquiVent®, Alliance Pharmaceutical Corp.; San Diego, CA), which is currently the perfluorocarbon most commonly used in clinical studies, is radiopaque, although this is not a characteristic of all of these fluids.


Functional Residual Capacity Congenital Diaphragmatic Hernia Alveolar Recruitment Pulmonary Compliance Partial Liquid Ventilation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shaffer TH, Wolfson MR, Clark LJr (1966) Liquid ventilation. Pediatr Pulmonol 14:102CrossRefGoogle Scholar
  2. 2.
    Clark LC Jr, Gollan F (1966) Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152:1755PubMedCrossRefGoogle Scholar
  3. 3.
    Shaffer TH, Moskowitz GD (1974) Demand-controlled liquid ventilation of the lungs. J Appl Physiol 36:208PubMedGoogle Scholar
  4. 4.
    Greenspan JS, Wolfson MR, Rubenstein SD et al (1989) Liquid ventilation of preterm baby. Lancet 2:1095PubMedCrossRefGoogle Scholar
  5. 5.
    Greenspan JS, Wolfson MR, Rubenstein SD et al (1990) Liquid ventilation of human preterm neonates. J Pediatr 117:106PubMedCrossRefGoogle Scholar
  6. 6.
    Fuhrman BP, Paczan PR, DeFrancisis M (1991) Perfluorocarbon-associated gas exchange. Crit Care Med 19:712PubMedCrossRefGoogle Scholar
  7. 7.
    Leach CL, Fuhrman BP, Morin FD et al (1993) Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Crit Care Med 21:1270PubMedCrossRefGoogle Scholar
  8. 8.
    Overbeck MC, Pranikoff T, Yadao CM et al (1996) The efficacy of perfluorocarbon liquid ventilation in a large animal model of acute respiratory failure. Critical Care Medicine 24:1208PubMedCrossRefGoogle Scholar
  9. 9.
    Hirschl RB, Tooley R, Parent AC et al (1995) Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. A study model in a setting of severe respiratory failure. Chest 108:500PubMedCrossRefGoogle Scholar
  10. 10.
    Herman LJ, Fuhrman BP, Kaiser R et al (1995) Perfluorocarbon associated gas exchange in normal and acid-injured-large sheep. Critical Care Medicine 23:A264CrossRefGoogle Scholar
  11. 11.
    Nesti FD, Fuhrman BP, Papo MC et al (1994) Perfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med 22:1445PubMedCrossRefGoogle Scholar
  12. 12.
    Tutuncu AS, Faithfull NS, Lachmann B (1993) Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dosedependent improvement of gas exchange. Crit Care Med 21:962PubMedCrossRefGoogle Scholar
  13. 13.
    Tooley R, Hirschl RB, Parent A et al (1996) Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis. Critical Care Medicine 24:268PubMedCrossRefGoogle Scholar
  14. 14.
    Gattinoni L, D’Andrea L, Pelosi P et al (1993) Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. Journal of American Medical Association 269:2122CrossRefGoogle Scholar
  15. 15.
    Hirschl RB, Overbeck MC, Parent A et al (1994) Liquid ventilation provides uniform distribution of perfluorocarbon in the setting of respiratory failure. Surgery 116:159PubMedGoogle Scholar
  16. 16.
    Quintel M, RB H, Roth H et al (1995) Assessment of perfluorocarbon (PFC) distribution during partial liquid ventilation (PLV) in the setting of acute respiratory failure. Am J Respir Crit Care Med 151:A446Google Scholar
  17. 17.
    Gauger PG, Overbeck MC, Chamber SD et al (1995) Perfluorocarbon partial liquid ventilation improves gas exchange while augmenting decreased functional residual capacity in an animal model of acute lung injury. Surgery Forum 46:669Google Scholar
  18. 18.
    Lowe C, Shaffer T (1986) Pulmonary vascular resistance in the fluorocarbon-filled lung. J Appl Physiol 60:154PubMedGoogle Scholar
  19. 19.
    Wilcox DT, Glick PL, Karamanoukian HL et al (1995) Perfluorocarbon-associated gas exchange improves pulmonary mechanics, oxygenation, ventilation, and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia lamb model. Crit Care Med 23:1858PubMedCrossRefGoogle Scholar
  20. 20.
    Hirschl RB, Parent A, Tooley R et al (1995) Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg 221:79PubMedCrossRefGoogle Scholar
  21. 21.
    Hirschl RB, Pranikoff P, Wise C et al (1996) Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 275:383PubMedCrossRefGoogle Scholar
  22. 22.
    Leach CL, Greenspan JS, Rubenstein SD et al (1994) Partial liquid ventilation with perflubron (LiquiVentTM): A pilot safety and efficacy study in premature newborns with severe RDS who have failed conventional therapy and exogenous surfactant. Presented at the American Academy of Pediatrics Meeting, Dallas, TXGoogle Scholar
  23. 23.
    Hirschl RB, Pranikoff T, Gauger P et al (1995) Liquid ventilation in adults, children, and fullterm neonates: preliminary report. The Lancet 346:1201CrossRefGoogle Scholar
  24. 24.
    Pranikoff T, Gauger P, Hirschl RB (1996) Partial liquid ventilation in newborn patients with congenital diaphragmatic hernia. J Ped Surg 31:613CrossRefGoogle Scholar
  25. 25.
    Gauger PG, Pranikoff T, Schreiner RJ et al (1996) Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 24:16PubMedCrossRefGoogle Scholar
  26. 26.
    Kazerooni EA, Pranikoff T, Cascade PN et al (1996) Perfluorocarbon partial liquid ventilation during extracorporeal life support in adults: radiographic appearance. Radiology 198:137PubMedGoogle Scholar
  27. 27.
    Hirschl RB et al unpublished resultsGoogle Scholar
  28. 28.
    Toro-Figueroa LO, Melinoes JN, Curtis SE et al (1996) Perflubron partial liquid ventilation (PLV) in children with ARDS: A safety and efficacy pilot study. Crit Care Med 24:A150Google Scholar
  29. 29.
    Hirschl RB (1996) Pulmonary function during liquid ventilation. In: Donn S Neonatal and pediatric pulmonary graphic analysis: Principles and clinical applications. Mount Kisco, NY, Futura publishing (in press)Google Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • R. B. Hirschl

There are no affiliations available

Personalised recommendations